Autres langues Kwality Pharmaceuticals Limited

Actions

KPL6

INE552U01010

Marché Fermé - Bombay S.E. Autres places de cotation 12:19:01 26/04/2024			Varia. 5j.	Varia. 1 janv.
507 ^INR	+1,36%		+13,03%	+26,81%

06/02	Kwality Pharmaceuticals Limited publie ses résultats pour les neuf mois clos le 31 décembre 2023	CI
2023	Kwality Pharmaceuticals Limited publie ses résultats pour le deuxième trimestre et le semestre clos le 30 septembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Kwality Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	06/02
Kwality Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	04/11
Kwality Pharmaceuticals Limited Provides Update on Resumption of Operations At Amritsar	07/10/23
Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/08/23
Kwality Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	27/05/23
Kwality Pharmaceuticals Discloses Completion of EU GMP Inspection at Himachal Pradesh, India Unit	25/04/23
Kwality Pharmaceuticals Limited Receives ANVISA Approval for Cephalosporin Plant (Unit -II)	30/03/23
Kwality Pharmaceuticals Limited Announces Change in Directorate	18/03/23
Kwality Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	14/02/23
Bulgarian Drug Agency to Conduct Audit on Kwality Pharmaceuticals' Plant in Himachal Pradesh, India	28/12/22
Kwality Pharmaceuticals to Bring Oncology Injection in Brazil	21/12/22
Kwality Pharmaceuticals to Market Oncology Injection in Brazil	15/12/22
Kwality Pharmaceuticals Received ANVISA Approval For Oncology Injection	15/12/22
Kwality Pharmaceuticals Receives ANVISA Approval For Oncology Injection	15/12/22
Kwality Pharmaceuticals Limited Announces the Resignation of Sachin Seth as Non- Executive and Non Independent Director	19/11/22
Kwality Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/11/22
ICRA Assigns BBB Rating on Kwality Pharmaceuticals' Bank Loans; Outlook Stable	21/09/22
Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	13/08/22
Kwality Pharmaceuticals Gets In-Principle Approval to Migrate to BSE Main Board	03/06/22
Kwality Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2023	28/05/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Kwality Pharmaceuticals Limited

Actions

KPL6

INE552U01010

Autres langues

Filtres